Health Care & Life Sciences » Pharmaceuticals | Santen Pharmaceutical Co. Ltd.

Santen Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
146,260
161,831
195,291
199,096
224,942
234,026
Cost of Goods Sold (COGS) incl. D&A
58,198
61,171
80,058
83,333
95,324
99,861
Gross Income
88,062
100,660
115,233
115,763
129,618
134,165
SG&A Expense
57,849
65,551
78,371
82,462
90,981
92,923
EBIT
-
34,995
36,502
-
38,637
41,242
Unusual Expense
755
290
43,651
841
381
1,458
Non Operating Income/Expense
1,061
1,177
657
2,425
1,043
3,152
Interest Expense
6
91
96
61
196
7
Pretax Income
30,361
35,863
79,470
30,055
39,261
43,117
Income Tax
10,643
11,831
26,097
8,331
4,000
11,174
Consolidated Net Income
19,718
24,032
53,373
21,724
35,261
31,942
Net Income
19,718
24,032
53,373
21,717
35,247
31,953
Net Income After Extraordinaries
19,718
24,032
53,373
21,717
35,247
31,953
Net Income Available to Common
19,718
24,032
53,373
21,731
35,247
31,953
EPS (Basic)
47.78
58.18
128.99
52.96
86.73
78.67
Basic Shares Outstanding
413
413
414
410
406
406
EPS (Diluted)
47.63
57.93
128.41
52.76
86.42
78.43
Diluted Shares Outstanding
414
415
416
412
408
407
EBITDA
32,821
41,953
45,840
43,183
49,533
52,211
Other Operating Expense
233
114
360
-
-
-
Non-Operating Interest Income
81
72
70
81
157
186
Minority Interest Expense
-
-
-
7
14
11

About Santen Pharmaceutical Co.

View Profile
Address
Grand Front Osaka Tower A, 25/F
Osaka Osaka 530
Japan
Employees -
Website http://www.santen.co.jp
Updated 07/08/2019
Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the Pharmaceuticals and Other segments. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.